Reasons patients give to use or not to use immunomodulating agents for multiple sclerosis
Author:
Publisher
Wiley
Subject
Neurology (clinical),Neurology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1468-1331.2011.03411.x/fullpdf
Reference11 articles.
1. Disease modifying therapies in multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines;Goodin;Neurology,2002
2. League table puts pressure on nations to improve MS care;Anonymous;Lancet Neurol,2008
3. Interrupted therapy: stopping and switching of the beta-interferons prescribed for MS;Tremlett;Neurology,2003
4. Adherence to the immunomodulatory drugs for multiple sclerosis: contrasting factors affect stopping drug and missing doses;Tremlett;Pharmacoepidemiol Drug Saf,2008
5. A post-marketing study on interferon beta 1b and 1a treatment in relapsing-remitting multiple sclerosis: different response in drop-outs and treated patients;Milanese;J Neurol Neurosurg Psychiatry,2003
Cited by 24 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A future of AI-driven personalized care for people with multiple sclerosis;Frontiers in Immunology;2024-08-19
2. A cross-sectional analysis of persistence to disease-modifying therapies in treatment naïve and experienced patients with relapsing multiple sclerosis at a health-system specialty pharmacy;Multiple Sclerosis and Related Disorders;2022-07
3. Patient-based benefit-risk assessment of medicines: development, refinement, and validation of a content search strategy to retrieve relevant studies;Journal of the Medical Library Association;2021-11-28
4. The role of expectations and future-oriented cognitions in quality of life of people with multiple sclerosis: A systematic review;Multiple Sclerosis and Related Disorders;2021-11
5. Monitoring, Switching, and Stopping Multiple Sclerosis Disease-Modifying Therapies;CONTINUUM: Lifelong Learning in Neurology;2019-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3